Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Clinical trial NCT00328965 · COMPLETED

Trial details

NCT number: NCT00328965
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Essential Hypertension

Start date: 2004-11-01
Primary completion: 2006-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.